Skip to main content

Adagene Inc. (ADAG)

NASDAQ: ADAG · IEX Real-Time Price · USD
1.93
+0.15 (8.51%)
At close: Dec 29, 2023, 4:00 PM
1.87
-0.06 (-3.18%)
After-hours: Dec 29, 2023, 4:17 PM EST

Adagene Revenue

Adagene had revenue of $22.67M in the twelve months ending June 30, 2023. In the year 2022, Adagene had annual revenue of $9.29M, a decrease of -8.67%.

Revenue (ttm)
$22.67M
Revenue Growth
-8.67%
P/S Ratio
3.56
Revenue / Employee
$91,392
Employees
248
Market Cap
80.62M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20229.29M-882.53K
-8.67%
Dec 31, 202110.18M9.47M
1,351.71%
Dec 31, 2020700.91K220.91K
46.02%
Dec 31, 2019480.00K-1.03M
-68.24%
Dec 31, 20181.51M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Cutera 246.37M
GeneDx Holdings 206.50M
Prenetics Global 68.79M
Cidara Therapeutics 56.54M
Champions Oncology 49.98M
CollPlant Biotechnologies 10.72M
Clearside Biomedical 2.21M
Revenue Rankings

ADAG News

More News